Skip Navigation

European Heart Journal 2001 22(16):1374-1450; doi:10.1053/euhj.2001.2824
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (254)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Priori, S.G.
Right arrow Articles by Zipes, D.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priori, S.G.
Right arrow Articles by Zipes, D.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Task Force Report

Task Force on Sudden Cardiac Death of the European Society of Cardiology

S.G. Priorif1, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, B.J. Maron, W.J. McKenna, A.K. Pedersen, U. Ravens, P.J. Schwartz, M. Trusz-Gluza, P. Vardas, H.J.J. Wellens and D.P. Zipes

f1 Correspondence: Silvia G. Priori, MD, PhD, FESC, Chairman Task Force on Sudden Cardiac Death, European Society of Cardiology, Fondazione Salvatore Maugeri, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy. E-mail:spriori@fsm.it

References

  1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. Braunwald E. Heart disease: a textbook of cardiovascular medicine. New York:: WB Saunders Publishing Co; 1997. p. 742–779
  2. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457–464[Abstract/Free Full Text]
  3. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation. 1996;93:519–524[Abstract/Free Full Text]
  4. Narang R, Cleland JG, Erhardt L. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J. 1996;17:1390–1403[Abstract/Free Full Text]
  5. Thomas AC, Knapman PA, Krikler DM, Davies MJ. Community study of the causes of ‘natural’ sudden death. BMJ. 1988;297:1453–1456[Abstract/Free Full Text]
  6. Leach IH, Blundell JW, Rowley JM, Turner DR. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. Eur Heart J. 1995;16:1181–1185[Abstract/Free Full Text]
  7. Goraya TY, Jacobsen SJ, Belau PG, Weston SA, Kottke TE, Roger VL. Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota. Mayo Clin Proc. 2000;75:681–687[Abstract]
  8. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137–1140[Abstract]
  9. Carveth SW, Olson D, Bechtel J. Proceedings: Emergency medical care system. Lincoln (Beb) mobile heart team. Arch Surg. 1974;108:528–530[Abstract/Free Full Text]
  10. Vertesi L. The paramedic ambulance: a Canadian experience. Can Med Assoc J. 1978;119:25–29[Abstract]
  11. Bachman JW, McDonald GS, O'Brien PC. A study of out-of-hospital cardiac arrests in northeastern Minnesota. JAMA. 1986;256:477–483[Abstract/Free Full Text]
  12. Becker LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluating survival rates. Ann Emerg Med. 1993;22:86–91[CrossRef][Web of Science][Medline]
  13. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Eur Heart J. 1997;18:1231–1248[Free Full Text]
  14. Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997;30:1500–1505[Abstract]
  15. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85:I2–10[Medline]
  16. Gillum RF. Sudden coronary death in the United States: 1980–1985. Circulation. 1989;79:756–765[Abstract/Free Full Text]
  17. Kannel, WB, Abbott, RD, Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study, N Engl J Med 1984, 311, 1144, 47
  18. McDonagh TA, Morrison CE, Lawrence A. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–833[CrossRef][Web of Science][Medline]
  19. Cupples LA, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death. Circulation. 1992;85:I11–I18[Medline]
  20. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995;91:1749–1756[Abstract/Free Full Text]
  21. Sexton PT, Walsh J, Jamrozik K, Parsons R. Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust N Z J Med. 1997;27:45–50[Web of Science][Medline]
  22. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99:1978–1983[Abstract/Free Full Text]
  23. Kannel WB, Gagnon DR, Cupples LA. Epidemiology of sudden coronary death: population at risk. Can J Cardiol. 1990;6:439–444[Web of Science][Medline]
  24. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88:180–185[Abstract/Free Full Text]
  25. Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J. 1993;70:49–55[Abstract/Free Full Text]
  26. Kannel WB, Cupples LA, D'Agostino RB, Stokes J. Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study. Hypertension. 1988;11:II45–II50[Medline]
  27. Weijenberg MP, Feskens EJ, Kromhout D. Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men (the Zutphen Elderly Study). J Hypertens. 1996;14:1159–1166[CrossRef][Web of Science][Medline]
  28. Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens Suppl. 1991;9:S3–S8[Medline]
  29. Clark LT. Anatomic substrate differences between black and white victims of sudden cardiac death: hypertension, coronary artery disease, or both? Clin Cardiol. 1989;12:IV13–IV17[Medline]
  30. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454–1459[Abstract/Free Full Text]
  31. Staessen JA, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens. 1999;13:859–863[CrossRef][Web of Science][Medline]
  32. Collins R, Peto R, MacMahon S. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–838[CrossRef][Web of Science][Medline]
  33. Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307[Abstract/Free Full Text]
  34. Downs JR, Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615–1622[Abstract/Free Full Text]
  35. Circulation. 1994;89:1333–1445[Medline]
  36. Albert CM, Hennekens CH, O'Donnell CJ. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23–28[Abstract/Free Full Text]
  37. Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921–926[Abstract/Free Full Text]
  38. Lemaitre RN, Siscovick DS, Raghunathan TE, Weinmann S, Arbogast P, Lin DY. Leisure-time physical activity and the risk of primary cardiac arrest. Arch Intern Med. 1999;159:686–690[Abstract/Free Full Text]
  39. Scragg R, Stewart A, Jackson R, Beaglehole R. Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. Am J Epidemiol. 1987;126:77–85[Abstract/Free Full Text]
  40. Aberg H, Lithell H, Selinus I, Hedstrand H. Alcohol intemperance and social disability as risk factors for different causes of death. Acta Med Scand. 1986;220:351–359[Web of Science][Medline]
  41. Day CP, James OF, Butler TJ, Campbell RW. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet. 1993;341:1423–1428[CrossRef][Web of Science][Medline]
  42. Vreede-Swagemakers JJ, Gorgels AP, Weijenberg MP. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol. 1999;52:601–607[CrossRef][Web of Science][Medline]
  43. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med. 1999;159:585–592[Abstract/Free Full Text]
  44. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 1997;145:899–908[Abstract/Free Full Text]
  45. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 1985;5:141B–149B[Medline]
  46. Escobedo LG, Caspersen CJ. Risk factors for sudden coronary death in the United States. Epidemiology. 1997;8:175–180[Web of Science][Medline]
  47. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation. 1996;93:2033–2036[Abstract/Free Full Text]
  48. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271–275[Abstract]
  49. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation. 1995;91:2591–2595[Abstract/Free Full Text]
  50. Suhonen O, Reunanen A, Knekt P, Aromaa A. Risk factors for sudden and non-sudden coronary death. Acta Med Scand. 1988;223:19–25[Web of Science][Medline]
  51. De Bacquer D, De Backer G, Kornitzer M, Myny K, Doyen Z, Blackburn H. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol. 1998;32:680–685[Abstract/Free Full Text]
  52. Kors JA, de Bruyne MC, Hoes AW. T-loop morphology as a marker of cardiac events in the elderly. J Electrocardiol. 1998;31:54–59[CrossRef][Web of Science][Medline]
  53. Burton F, Cobbe SM. Dispersion of ventricular repolarization and refractoriness. Cardiovas Res. 2001;50:10–23[Free Full Text]
  54. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516–1523[Abstract/Free Full Text]
  55. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994;90:779–785[Abstract/Free Full Text]
  56. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation. 1998;97:467–472[Abstract/Free Full Text]
  57. Manttari M, Oikarinen L, Manninen V, Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart. 1997;78:268–272[Abstract/Free Full Text]
  58. Friedlander Y, Siscovick DS, Weinmann S. Family history as a risk factor for primary cardiac arrest. Circulation. 1998;97:155–160[Abstract/Free Full Text]
  59. Milner PG, Platia EV, Reid PR, Griffith LS. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. Am J Cardiol. 1985;56:588–592[CrossRef][Web of Science][Medline]
  60. Marcus FI, Cobb LA, Edwards JE. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol. 1988;61:8–15[CrossRef][Web of Science][Medline]
  61. Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1999;33:1895–1902[Abstract/Free Full Text]
  62. Statters DJ, Malik M, Redwood S, Hnatkova K, Staunton A, Camm AJ. Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era. Am J Cardiol. 1996;77:133–138[CrossRef][Web of Science][Medline]
  63. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701–1709[Abstract/Free Full Text]
  64. Patterson E, Holland K, Eller BT, Lucchesi BR. Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. Am J Cardiol. 1982;50:1414–1423[CrossRef][Web of Science][Medline]
  65. Di Maio VJ, Di Maio DJ. Incidence of coronary thrombosis in sudden death due to coronary artery disease. Am J Forensic Med Pathol. 1993;14:273–275[Web of Science][Medline]
  66. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J. 1989;10:203–208[Abstract/Free Full Text]
  67. Bayes dL, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151–159[CrossRef][Web of Science][Medline]
  68. Myerburg RJ, Kessler KM, Zaman L, Conde CA, Castellanos A. Survivors of prehospital cardiac arrest. JAMA. 1982;247:1485–1490[Abstract/Free Full Text]
  69. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675–1680[Abstract/Free Full Text]
  70. Panidis IP, Morganroth J. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983;2:798–805[Abstract]
  71. Roelandt J, Klootwijk P, Lubsen J, Janse MJ. Sudden death during longterm ambulatory monitoring. Eur Heart J. 1984;5:7–20[Abstract/Free Full Text]
  72. Kempf FC Jr, Josephson ME. Cardiac arrest recorded on ambulatory electrocardiograms. Am J Cardiol. 1984;53:1577–1582[CrossRef][Web of Science][Medline]
  73. Zehender M, Buchner C, Meinertz T, Just H. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation. 1992;85:596–605[Abstract/Free Full Text]
  74. Lancet. 1999;353:2001–2007[CrossRef][Web of Science][Medline]
  75. Rankin AS, Cobbe SM. Arrhythmias and sudden death in heart failure: can we prevent them? McMurray JJV, Cleland. Heart failure in clinical practice. London: Martin Dunitz Ltd; 1996. p. 189–205
  76. Uretsky BF, Thygesen K, Armstrong PW. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000;102:611–616[Abstract/Free Full Text]
  77. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 1990;65:42I–48I[Medline]
  78. Yap Y, Duong T, Bland M. Left ventricular ejection fraction in the trombolytic era remains a powerful predictor of long-term but not short-term all-cause, cardiac and arrhythmic mortality after myocardial infarction–a secondary meta-analysis of 2828 patients. Heart. 2000;83:55
  79. Stevenson WG, Ridker PM. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? JAMA. 1996;276:481–485[Abstract/Free Full Text]
  80. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 1996;27:270–276[Abstract]
  81. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–484[CrossRef][Web of Science][Medline]
  82. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51[Abstract/Free Full Text]
  83. Nicolosi GL, Latini R, Marino P. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Eur Heart J. 1996;17:1646–1656[Abstract/Free Full Text]
  84. Maggioni AP, Zuanetti G, Franzosi MG. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87:312–322[Abstract/Free Full Text]
  85. Farrell TG, Bashir Y, Cripps T. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687–697[Abstract]
  86. McClements BM, Adgey AA. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1993;21:1419–1427[Abstract]
  87. Richards DA, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 1991;83:756–763[Abstract/Free Full Text]
  88. Mushlin AI, Hall WJ, Zwanziger J. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation. 1998;97:2129–2135[Abstract/Free Full Text]
  89. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890[Abstract/Free Full Text]
  90. Andresen D, Steinbeck G, Bruggemann T. Can the MADIT results be applied to myocardial infarction patients at hospital discharge? J Am Coll Cardiol. 1998;31:308
  91. Steinberg JS, Regan A, Sciacca RR, Bigger JT Jr, Fleiss JL. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol. 1992;69:13–21[Web of Science][Medline]
  92. Steinberg JS, Hochman JS, Morgan CD. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. Circulation. 1994;90:746–752[Abstract/Free Full Text]
  93. Malik M, Kulakowski P, Odemuyiwa O. Effect of thrombolytic therapy on the predictive value of signal-averaged electrocardiography after acute myocardial infarction. Am J Cardiol. 1992;70:21–25[CrossRef][Web of Science][Medline]
  94. Hermosillo AG, Araya V, Casanova JM. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG. Coron Artery Dis. 1995;6:973–983[Web of Science][Medline]
  95. Cain ME, Anderon JL, Arnsdorf MF, Mason JW, Scheinman MM, Waldo AL. ACC Consensus Document on Signal-Averaged Electrocardiography. J Am Coll Cardiol. 1996;27:238–249[Web of Science][Medline]
  96. Zuanetti G, Neilson JM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation. 1996;94:432–436[Abstract/Free Full Text]
  97. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol. 2000;35:1263–1275[Abstract/Free Full Text]
  98. Schmidt G, Malik M, Barthel P. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353:1390–1396[CrossRef][Web of Science][Medline]
  99. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978;57:1074–1077[Abstract/Free Full Text]
  100. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991;83:1888–1894[Abstract/Free Full Text]
  101. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation. 1998;97:2543–2550[Abstract/Free Full Text]
  102. Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol. 1998;9:1258–1268[Web of Science][Medline]
  103. Ikeda T, Sakata T, Takami M. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol. 2000;35:722–730[Abstract/Free Full Text]
  104. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med. 1997;126:561–582[Abstract/Free Full Text]
  105. Wellens HJ, Doevendans P, Smeets J. Arrhythmia risk: electrophysiological studies and monophasic action potentials. Pacing Clin Electrophysiol. 1997;20:2560–2565[CrossRef][Medline]
  106. Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation. 1997;96:1888–1892[Abstract/Free Full Text]
  107. Andresen D, Steinbeck G, Bruggemann T. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol. 1999;33:131–138[Abstract/Free Full Text]
  108. Hohnloser SH, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation. 1994;90:1747–1756[Abstract/Free Full Text]
  109. de Chillou C, Sadoul N, Bizeau O. Prognostic value of thrombolysis, coronary artery patency, signal-averaged electrocardiography, left ventricular ejection fraction, and Holter electrocardiographic monitoring for life-threatening ventricular arrhythmias after a first acute myocardial infarction. Am J Cardiol. 1997;80:852–858[CrossRef][Web of Science][Medline]
  110. N Engl J Med. 1989;320:618–627[Abstract]
  111. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476–485[Abstract/Free Full Text]
  112. Eur Heart J. 1996;17:43–63[Free Full Text]
  113. Circulation. 1998;97:2202–2212[Abstract/Free Full Text]
  114. Ziesche S, Rector ST, Cohn JN. Interobserver discordance in the classification of mechanisms of death in studies of heart failure. J Card Fail. 1995;1:127–132[CrossRef][Medline]
  115. Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–310[Abstract]
  116. N Engl J Med. 1991;325:293–302[Abstract]
  117. Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction—evidence from clinical trials. N Engl J Med. 1996;335:1660–1667[Free Full Text]
  118. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1999;33:598–604[Abstract/Free Full Text]
  119. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–717[Abstract/Free Full Text]
  120. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA. 1999;282:2340–2346[Abstract/Free Full Text]
  121. Lancet. 1999;354:447–455[CrossRef][Web of Science][Medline]
  122. Lancet. 1994;343:311–322[CrossRef][Web of Science][Medline]
  123. Lancet. 1988;2:349–360[Medline]
  124. Topol EJ, Mark DB, Lincoff AM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet. 1999;354:2019–2024[CrossRef][Web of Science][Medline]
  125. Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA. 1999;282:2058–2067[Abstract/Free Full Text]
  126. Collins R, MacMahon S, Flather M. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ. 1996;313:652–659[Abstract/Free Full Text]
  127. Weaver WD, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–2098[Abstract/Free Full Text]
  128. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 1995;332:80–85[Abstract/Free Full Text]
  129. Flather MD, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 2000;355:1575–1581[CrossRef][Web of Science][Medline]
  130. Lancet. 1993;342:821–828[Web of Science][Medline]
  131. Kober L, Torp-Pedersen C, Carlsen JE. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670–1676[Abstract/Free Full Text]
  132. Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669–677[Abstract]
  133. Lancet. 1995;345:669–685[CrossRef][Web of Science][Medline]
  134. Lancet. 1994;343:1115–1122[Web of Science][Medline]
  135. N Engl J Med. 1992;327:685–691[Abstract]
  136. N Engl J Med. 1987;316:1429–1435[Abstract]
  137. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure : insights from the Randomized Aldactone Evaluation Study (RALES). Circulation. 2000;102:2700–2706[Abstract/Free Full Text]
  138. Lancet. 1994;344:1383–1389[CrossRef][Web of Science][Medline]
  139. Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–1009[Abstract/Free Full Text]
  140. N Engl J Med. 1998;339:1349–1357[Abstract/Free Full Text]
  141. Marchioli R, Valagussa F. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. Eur Heart J. 2000;21:949–952[Free Full Text]
  142. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988;1:1088–1092[Web of Science][Medline]
  143. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992;268:240–248[Abstract/Free Full Text]
  144. Teo KK, Yusuf S. Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs. 1993;46:347–359[Web of Science][Medline]
  145. Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994;343:816–819[CrossRef][Web of Science][Medline]
  146. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol. 1995;75:391–393[CrossRef][Web of Science][Medline]
  147. Lancet. 1986;1:397–402[CrossRef][Medline]
  148. Wilcox RG, von der LG, Olsson CG, Jensen G, Skene AM, Hampton JR. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet. 1990;335:1175–1178[CrossRef][Web of Science][Medline]
  149. N Engl J Med. 1986;314:1465–1471[Abstract]
  150. Lancet. 1990;335:427–431[CrossRef][Web of Science][Medline]
  151. Lancet. 1990;336:71–75[CrossRef][Web of Science][Medline]
  152. Lancet. 1992;339:753–770[Web of Science][Medline]
  153. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  154. Cannon CP, McCabe CH, Diver DJ. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 1994;24:1602–1610[Abstract]
  155. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. A review. Drugs. 1992;44:293–325[Web of Science][Medline]
  156. BMJ. 1994;308:81–106[Abstract/Free Full Text]
  157. Hass WK, Easton JD, Adams HP. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501–507[Abstract]
  158. Lancet. 1994;343:499–503[Web of Science][Medline]
  159. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990;323:147–152[Abstract]
  160. N Engl J Med. 1982;307:701–708[Abstract]
  161. Yusuf S, Zucker D, Peduzzi P. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563–570[CrossRef][Web of Science][Medline]
  162. Lancet. 1999;354:708–715[CrossRef][Web of Science][Medline]
  163. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularization during Instability in Coronary artery disease. Lancet. 2000;356:9–16[CrossRef][Web of Science][Medline]
  164. Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 1987;9:989–995[Abstract]
  165. Pizzetti G, Belotti G, Margonato A, Cappelletti A, Chierchia SL. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction. J Am Coll Cardiol. 1996;28:837–845[Abstract]
  166. Eur Heart J. 2000;21:1502–1513[Abstract/Free Full Text]
  167. Topol EJ, Ferguson JJ, Weisman HF. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. JAMA. 1997;278:479–484[Abstract/Free Full Text]
  168. Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998;31:1240–1245[Abstract/Free Full Text]
  169. Stone GW, Brodie BR, Griffin JJ. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol. 1998;31:23–30[Abstract/Free Full Text]
  170. Maillard L, Hamon M, Khalife K. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2000;35:1729–1736[Abstract/Free Full Text]
  171. Grines CL, Cox DA, Stone GW. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341:1949–1956[Abstract/Free Full Text]
  172. Brener SJ, Barr LA, Burchenal JE. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 1998;98:734–741[Abstract/Free Full Text]
  173. Neumann FJ, Blasini R, Schmitt C. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695–2701[Abstract/Free Full Text]
  174. Schomig A, Kastrati A, Dirschinger J. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 2000;343:385–391[Abstract/Free Full Text]
  175. O'Rourke RA. Role of myocardial revascularization in sudden cardiac death. Circulation. 1992;85:I112–I117[Medline]
  176. Daoud EG, Niebauer M, Kou WH. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death. Am Heart J. 1995;130:277–280[CrossRef][Web of Science][Medline]
  177. Packer M, Carver JR, Rodeheffer RJ. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468–1475[Abstract]
  178. N Engl J Med. 1997;336:525–533[Abstract/Free Full Text]
  179. Circulation. 1991;84:1831–1851[Abstract/Free Full Text]
  180. N Engl J Med. 1989;321:406–412[Abstract]
  181. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA. 1988;260:1910–1916[Abstract/Free Full Text]
  182. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993;270:1589–1595[Abstract/Free Full Text]
  183. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–371[Web of Science][Medline]
  184. Lancet. 2001;357:1385–1390[CrossRef][Web of Science][Medline]
  185. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27–34[Abstract]
  186. Lancet. 1999;353:9–13[CrossRef][Web of Science][Medline]
  187. Lancet. 1997;350:1417–1424[CrossRef][Web of Science][Medline]
  188. Waldo AL, Camm AJ, deRuyter H. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7–12[CrossRef][Web of Science][Medline]
  189. Torp-Pedersen C, Moller M, Bloch-Thomsen PE. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med. 1999;341:857–865[Abstract/Free Full Text]
  190. Kober L, Thomsen PE, Moller M. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomized trial. Lancet. 2000;356:2052–2058[CrossRef][Web of Science][Medline]
  191. N Engl J Med. 1992;327:227–233[Abstract]
  192. Echt DS, Liebson PR, Mitchell LB. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788[Abstract]
  193. Furberg CD, Hawkins CM, Lichstein E. Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation. 1984;69:761–765[Abstract/Free Full Text]
  194. Goldman L, Sia ST, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med. 1988;319:152–157[Abstract]
  195. Nuttal SL, Toescu V, Kendall MJ. Beta-blockade after myocardial infarction. BMJ. 2000;320:581[Free Full Text]
  196. Freemantle N, Cleland JG, Young P, Mason J, Harrison J. Beta-blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 2001;318:1730–1737
  197. Packer M, Bristow MR, Cohn JN. The effect of Cavedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355[Abstract/Free Full Text]
  198. Krum H. Beta-blockers in heart failure. Drugs. 1999;58:203–210[Web of Science][Medline]
  199. Eur Heart J. 1988;9:8–16[Abstract/Free Full Text]
  200. Cohn JN, Fowler MB, Bristow MR. Safety and efficacy of carvedilol in severe heart failure. J Card Fail. 1997;3:173–179[CrossRef][Medline]
  201. Held P. Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. Am J Cardiol. 1993;71:39C–44C[CrossRef][Medline]
  202. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. Beta-blockers and sudden cardiac death. Ann Intern Med. 1995;123:358–367[Abstract/Free Full Text]
  203. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497[Abstract/Free Full Text]
  204. Kennedy HL, Rosenson RS. Physician use of beta-adrenergic blocking therapy: a changing perspective. J Am Coll Cardiol. 1995;26:547–552[Web of Science][Medline]
  205. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115–121[Abstract/Free Full Text]
  206. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med. 1995;122:689–700[Abstract/Free Full Text]
  207. Julian DG, Camm AJ, Frangin G. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667–674[CrossRef][Web of Science][Medline]
  208. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675–682[CrossRef][Web of Science][Medline]
  209. Elizari MV, Martinez JM, Belziti C. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. Eur Heart J. 2000;21:198–205[Abstract/Free Full Text]
  210. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol. 1992;20:1056–1062[Abstract]
  211. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 1990;16:1711–1718[Abstract]
  212. Singh SN, Fletcher RD, Fisher SG. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333:77–82[Abstract/Free Full Text]
  213. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493–498[CrossRef][Web of Science][Medline]
  214. Garguichevich JJ, Ramos JL, Gambarte A. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am Heart J. 1995;130:494–500[CrossRef][Web of Science][Medline]
  215. Hamer AW, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. J Am Coll Cardiol. 1989;14:1768–1774[Abstract]
  216. Janse MJ, Malik M, Camm AJ, Julian DG, Frangin GA, Schwartz PJ. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Eur Heart J. 1998;19:85–95[Abstract/Free Full Text]
  217. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 1993;329:452–458[Abstract/Free Full Text]
  218. Haverkamp W, Martinez-Rubio A, Hief C. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. J Am Coll Cardiol. 1997;30:487–495[Abstract]
  219. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989;299:1187–1192[Abstract/Free Full Text]
  220. Am J Cardiol. 1990;66:779–785[CrossRef][Web of Science][Medline]
  221. Waters D, Lesperance J, Francetich M. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation. 1990;82:1940–1953[Abstract/Free Full Text]
  222. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol. 1991;67:1295–1297[CrossRef][Web of Science][Medline]
  223. Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322–324[Web of Science][Medline]
  224. Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med. 1987;107:635–641[CrossRef][Web of Science][Medline]
  225. Winkle RA, Mead RH, Ruder MA. Long-term outcome with the automatic implantable cardioverter–defibrillator. J Am Coll Cardiol. 1989;13:1353–1361[Abstract]
  226. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 1990;16:381–386[Abstract]
  227. Levine JH, Mellits ED, Baumgardner RA. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 1991;84:558–566[Abstract/Free Full Text]
  228. de Marchena E, Chakko S, Fernandez P. Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. Am J Cardiol. 1991;67:812–816[CrossRef][Web of Science][Medline]
  229. Newman D, Sauve MJ, Herre J. Survival after implantation of the cardioverter defibrillator. Am J Cardiol. 1992;69:899–903[CrossRef][Web of Science][Medline]
  230. Bardy GH, Hofer B, Johnson G. Implantable transvenous cardioverter-defibrillators. Circulation. 1993;87:1152–1168[Abstract/Free Full Text]
  231. Moss AJ, Hall WJ, Cannom DS. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940[Abstract/Free Full Text]
  232. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997;337:1569–1575[Abstract/Free Full Text]
  233. Denes P, Gillis AM, Pawitan Y, Kammerling JM, Wilhelmsen L, Salerno DM. Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol. 1991;68:887–896[CrossRef][Web of Science][Medline]
  234. Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Circulation. 1987;75:1178–1185[Abstract/Free Full Text]
  235. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation. 1990;82:350–358[Abstract/Free Full Text]
  236. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256–262[CrossRef][Web of Science][Medline]
  237. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation. 1988;78:816–824[Abstract/Free Full Text]
  238. Bocker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation. 1996;94:151–157[Abstract/Free Full Text]
  239. Am J Cardiol. 1993;72:280–287[CrossRef][Web of Science][Medline]
  240. N Engl J Med. 1997;337:1576–1583[Abstract/Free Full Text]
  241. Connolly SJ, Gent M, Roberts RS. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297–1302[Abstract/Free Full Text]
  242. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–754[Abstract/Free Full Text]
  243. Connolly SJ, Hallstrom AP, Cappato R. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21:2071–2078[Abstract/Free Full Text]
  244. Morady F, Harvey M, Kalbfleisch SJ, el Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363–372[Abstract/Free Full Text]
  245. Stevenson WG, Khan H, Sager P. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–1670[Abstract/Free Full Text]
  246. van Hemel NM, Kingma JH, Defauw JA. Left ventricular segmental wall motion score as a criterion for selecting patients for direct surgery in the treatment of postinfarction ventricular tachycardia. Eur Heart J. 1989;10:304–315[Abstract/Free Full Text]
  247. van Hemel NM, Kingma JH, Defauw JJ. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia. Eur Heart J. 1996;17:564–573[Abstract/Free Full Text]
  248. Murgatroyd F, Klein GJ, Krahn AD, Yee R, Roberts R. Undocumented syncope with inducible ventricular tachycardia is as malignant as documented symptomatic ventricular tachycardia/fibrilltion. A Canadian Implantable Defibrillator Study (CIDS) subgroup analysis (Abstr). Circulation. 1998;98:495[Free Full Text]
  249. Raitt MH, Renfroe EG, Epstein AE. ‘Stable’ ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Circulation. 2001;103:244–252[Abstract/Free Full Text]
  250. Domanski MJ, Sakseena S, Epstein AE. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol. 1999;34:1090–1095[Abstract/Free Full Text]
  251. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000;101:1660–1664[Abstract/Free Full Text]
  252. Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation. 2000;101:1638–1640[Free Full Text]
  253. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–785[Free Full Text]
  254. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–789[Abstract/Free Full Text]
  255. Maron BJ, Peterson EE, Maron MS, Peterson JE. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol. 1994;73:577–580[CrossRef][Web of Science][Medline]
  256. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127–133[CrossRef][Web of Science][Medline]
  257. Wigle ED, Sasson Z, Henderson MA. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1–83[CrossRef][Web of Science][Medline]
  258. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987;60:123–129[CrossRef][Web of Science][Medline]
  259. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and haemodynamic features. Am J Cardiol. 1981;47:532–538[CrossRef][Web of Science][Medline]
  260. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;11:147–153[Abstract]
  261. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child. 1984;59:971–975[Abstract/Free Full Text]
  262. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749–755[Abstract]
  263. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281:650–655[Abstract/Free Full Text]
  264. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995;26:1529–1536[Abstract]
  265. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276:199–204[Abstract/Free Full Text]
  266. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;7:701–704[Abstract]
  267. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:1339–1344[CrossRef][Web of Science][Medline]
  268. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20–36[Abstract/Free Full Text]
  269. Watkins H, McKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058–1064[Abstract/Free Full Text]
  270. Sharma S, Elliott P, Whyte G. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2000;86:162–168[CrossRef][Web of Science][Medline]
  271. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982;65:1388–1394[Abstract/Free Full Text]
  272. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–1785[Abstract/Free Full Text]
  273. Elliott P, Gimeno Blanes JR, Mahon NG, Poloniecki J, McKenna WJ. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;:
  274. Elliott PM, Poloniecki J, Dickie S. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212–2218[Abstract/Free Full Text]
  275. Varnava A, Baboonian C, Davison F. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart. 1999;82:621–624[Abstract/Free Full Text]
  276. Frenneaux MP, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 1990;82:1995–2002[Abstract/Free Full Text]
  277. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 1997;96:2987–2991[Abstract/Free Full Text]
  278. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation. 1991;84:686–696[Abstract/Free Full Text]
  279. Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:2044–2051[Abstract/Free Full Text]
  280. McKenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J. 1981;46:168–172[Abstract/Free Full Text]
  281. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981;48:252–257[CrossRef][Web of Science][Medline]
  282. Spirito P, Rapezzi C, Autore C. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994;90:2743–2747[Abstract/Free Full Text]
  283. McKenna WJ, Sadoul N, Slade AK, Saumarez RC. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Circulation. 1994;90:3115–3117[Free Full Text]
  284. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, haemodynamic, and electrophysiological findings. Circulation. 1992;86:730–740[Abstract/Free Full Text]
  285. Cecchi F, Maron BJ, Epstein SE. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol. 1989;13:1283–1288[Abstract]
  286. Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:1596–1601[Abstract/Free Full Text]
  287. Maron BJ, Shen WK, Link MS. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365–373[Abstract/Free Full Text]
  288. Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J. 1988;9:177–185[Abstract/Free Full Text]
  289. Saumarez RC, Slade AK, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation. 1995;91:2762–2768[Abstract/Free Full Text]
  290. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:796–804[Abstract]
  291. Maron BJ, Leyhe MJ, Casey SA. Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. Am J Cardiol. 2001;87:114–115[CrossRef][Web of Science][Medline]
  292. Fei L, Slade AK, Grace AA, Malik M, Camm AJ, McKenna WJ. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone. Pacing Clin Electrophysiol. 1994;17:2222–2227[CrossRef][Medline]
  293. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985;53:412–416[Abstract/Free Full Text]
  294. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart. 1998;79:331–336[Abstract/Free Full Text]
  295. Maron BJ, Olivotto I, Spirito P. Epidemiology of hypertrophic cardiomyopathy-related death; revisited in a large non-referral-based patients population. Circulation. 2000;102:858–864[Abstract/Free Full Text]
  296. Marcus FI, Fontaine GH, Guiraudon G. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384–398[Abstract/Free Full Text]
  297. Richardson P, McKenna W, Bristow M. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [news]. Circulation. 1996;93:841–842[Free Full Text]
  298. McKenna WJ, Thiene G, Nava A. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71:215–218[Free Full Text]
  299. Shen WK, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol. 1995;76:148–152[CrossRef][Web of Science][Medline]
  300. Goodin JC, Farb A, Smialek JE, Field F, Virmani R. Right ventricular dysplasia associated with sudden death in young adults. Mod Pathol. 1991;4:702–706[Web of Science][Medline]
  301. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364–369[Abstract/Free Full Text]
  302. Tabib A, Miras A, Taniere P, Loire R. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases. Eur Heart J. 1999;20:900–903[Abstract/Free Full Text]
  303. Rampazzo A, Nava A, Danieli GA. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 1994;3:959–962[Abstract/Free Full Text]
  304. McKoy G, Protonotarios N, Crosby A. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119–2124[CrossRef][Web of Science][Medline]
  305. Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J. 1996;17:1717–1722[Abstract/Free Full Text]
  306. Daliento L, Turrini P, Nava A. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol. 1995;25:655–664[Abstract]
  307. Berder V, Vauthier M, Mabo P. Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 1995;75:411–414[CrossRef][Web of Science][Medline]
  308. Peters S. Right ventricular cardiomyopathy: diffuse dilatation, focal dysplasia or biventricular disease. Int J Cardiol. 1997;62:63–67[CrossRef][Web of Science][Medline]
  309. Blomstrom-Lundqvist C, Sabel KG, Olsson SB. A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J. 1987;58:477–488[Abstract/Free Full Text]
  310. Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J. 1989;10:68–73[Abstract/Free Full Text]
  311. Corrado D, Basso C, Thiene G. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30:1512–1520[Abstract]
  312. Nava A, Thiene G, Canciani B. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol. 1988;12:1222–1228[Abstract]
  313. Benn M, Hansen PS, Pedersen AK. QT dispersion in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J. 1999;20:764–770[Abstract/Free Full Text]
  314. De Ambroggi L, Aime E, Ceriotti C, Rovida M, Negroni S. Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia: principal component analysis of the ST-T waves. Circulation. 1997;96:4314–4318[Abstract/Free Full Text]
  315. Turrini P, Angelini A, Thiene G. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 1999;83:1214–1219[CrossRef][Web of Science][Medline]
  316. Leclercq JF, Coumel P. Late potentials in arrhythmogenic right ventricular dysplasia. Prevalence, diagnostic and prognostic values. Eur Heart J. 1993;14:80–83[Abstract/Free Full Text]
  317. Mehta D, Goldman M, David O, Gomes JA. Value of quantitative measurement of signal-averaged electrocardiographic variables in arrhythmogenic right ventricular dysplasia: correlation with echocardiographic right ventricular cavity dimensions. J Am Coll Cardiol. 1996;28:713–719[Abstract]
  318. Hermida JS, Minassian A, Jarry G. Familial incidence of late ventricular potentials and electrocardiographic abnormalities in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 1997;79:1375–1380[CrossRef][Web of Science][Medline]
  319. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86:29–37[Abstract/Free Full Text]
  320. Lemery R, Brugada P, Janssen J, Cheriex E, Dugernier T, Wellens HJ. Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol. 1989;14:96–105[Abstract]
  321. Peters S. Left ventricular impairment in arrhythmogenic right ventricular dysplasia: what we can learn from angiography. Cardiology. 1995;86:473–476[Web of Science][Medline]
  322. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129–133[Abstract]
  323. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588–596[CrossRef][Web of Science][Medline]
  324. Leclercq JF, Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. Eur Heart J. 1989;10:61–67[Abstract/Free Full Text]
  325. Leclercq JF, Potenza S, Maison-Blanche P, Chastang C, Coumel P. Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol. 1996;28:720–724[Abstract]
  326. Fornes P, Ratel S, Lecomte D. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia—an autopsy study of 20 forensic cases. J Forensic Sci. 1998;43:777–783[Web of Science][Medline]
  327. Furlanello F, Bertoldi A, Dallago M. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol. 1998;21:331–335[CrossRef][Medline]
  328. Harada T, Aonuma K, Yamauchi Y. Catheter ablation of ventricular tachycardia in patients with right ventricular dysplasia: Identification of target sites by entrainment mapping techniques. Pacing Clin Electrophysiol. 1998;21:2547–2550[CrossRef][Medline]
  329. Ellison KE, Friedman PL, Ganz LI, Stevenson WG. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol. 1998;32:724–728[Abstract/Free Full Text]
  330. Link MS, Wang PJ, Haugh CJ. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 1997;1:41–48[CrossRef][Medline]
  331. Breithardt G, Wichter T, Haverkamp W. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J. 1994;127:1151–1158[CrossRef][Web of Science][Medline]
  332. Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation. 1989;80:564–572[Abstract/Free Full Text]
  333. Michels VV, Moll PP, Miller FA. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77–82[Abstract]
  334. Keeling PJ, Gang Y, Smith G. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417–421[Abstract/Free Full Text]
  335. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525–531[CrossRef][Web of Science][Medline]
  336. Di Lenarda A, Secoli G, Perkan A. Changing mortality in dilated cardiomyopathy. Br Heart J. 1994;72:S46–S51
  337. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564–1575[Free Full Text]
  338. Kelly P, Coats A. Variation in mode of sudden cardiac death in patients with dilated cardiomyopathy. Eur Heart J. 1997;18:879–880[Free Full Text]
  339. Tamburro P, Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J. 1992;124:1035–1045[CrossRef][Web of Science][Medline]
  340. Stewart RA, McKenna WJ, Oakley CM. Good prognosis for dilated cardiomyopathy without severe heart failure or arrhythmia. Q J Med. 1990;74:309–318[Web of Science][Medline]
  341. Hofmann T, Meinertz T, Kasper W. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J. 1988;116:1455–1463[CrossRef][Web of Science][Medline]
  342. Romeo F, Pelliccia F, Cianfrocca C, Cristofani R, Reale A. Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:138–140[CrossRef][Web of Science][Medline]
  343. Gradman A, Deedwania P, Cody R. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989;14:564–570[Abstract]
  344. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 1990;65:903–908[CrossRef][Web of Science][Medline]
  345. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1991;121:1124–1131[CrossRef][Web of Science][Medline]
  346. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993;21:110–116[Abstract]
  347. Knight BP, Goyal R, Pelosi F. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33:1964–1970[Abstract/Free Full Text]
  348. Kron J, Hart M, Schual-Berke S, Niles NR, Hosenpud JD, McAnulty JH. Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death. Chest. 1988;93:85–90[CrossRef][Web of Science][Medline]
  349. Meinertz T, Hofmann T, Kasper W. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1984;53:902–907[CrossRef][Web of Science][Medline]
  350. Wilber DJ. Evaluation and treatment of nonsustained ventricular tachycardia. Curr Opin Cardiol. 1996;11:23–31[CrossRef][Web of Science][Medline]
  351. Galinier M, Bounhoure JP. Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic? Arch Mal Coeur Vaiss. 1999;92:727–732[Web of Science][Medline]
  352. Steinberg J, Ehlert F, Cannon D. Dilated cardiomyopathy versus coronary artery disease in patients with VT/VF: differences in presentation and outcome in the arrhythmics versus implantable defibrillators (AVID) registry (Abstr). Circulation. 1997;96:15[Abstract/Free Full Text]
  353. Schwartz PJ, Priori SG, Napolitano C. The Long QT Syndrome. Zipes DP, Jalife J. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia: WB Saunders Co; 2000. p. 597–615
  354. Priori SG, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Eur Heart J. 1999;20:174–195[Free Full Text]
  355. Priori SG, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation. 1999;99:674–681[Free Full Text]
  356. Priori SG, Barhanin J, Hauer RN. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation. 1999;99:518–528[Abstract/Free Full Text]
  357. Locati EH, Zareba W, Moss AJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97:2237–2244[Abstract/Free Full Text]
  358. Moss AJ, Zareba W, Hall WJ. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623[Abstract/Free Full Text]
  359. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529–533[Abstract/Free Full Text]
  360. Moss AJ, Schwartz PJ, Crampton RS. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136–1144[Abstract/Free Full Text]
  361. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 1994;89:1681–1689[Abstract/Free Full Text]
  362. Schwartz PJ, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J. 1975;89:45–50[CrossRef][Web of Science][Medline]
  363. Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23:1541–1546[Abstract]
  364. Rashba EJ, Zareba W, Moss AJ. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation. 1998;97:451–456[Abstract/Free Full Text]
  365. Zareba W, Moss AJ, Schwartz PJ. Influence of genotype on the clinical course of the long-QT syndrome. N Engl J Med. 1998;339:960–965[Abstract/Free Full Text]
  366. Schwartz PJ, Priori SG, Spazzolini C. Genotype-phenotype correlation in the long-QT syndrome:gene-specific triggers for life-threatening arrhythmias. Circulation (Online). 2001;103:89–95[Abstract/Free Full Text]
  367. Marks ML, Trippel DL, Keating MT. Long QT syndrome associated with syndactyly identified in females. Am J Cardiol. 1995;76:744–745[CrossRef][Web of Science][Medline]
  368. Bhandari AK, Shapiro WA, Morady F, Shen EN, Mason J, Scheinman MM. Electrophysiologic testing in patients with the long QT syndrome. Circulation. 1985;71:63–71[Abstract/Free Full Text]
  369. Napolitano C, Schwartz PJ, Brown AM. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol. 2000;11:691–696[Web of Science][Medline]
  370. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399–411[CrossRef][Web of Science][Medline]
  371. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation. 1991;84:503–511[Abstract/Free Full Text]
  372. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation. 1991;84:1524–1529[Abstract/Free Full Text]
  373. Dorostkar PC, Eldar M, Belhassen B, Scheinman MM. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation. 1999;100:2431–2436[Abstract/Free Full Text]
  374. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–1396[Abstract]
  375. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97:457–460[Abstract/Free Full Text]
  376. Priori SG, Napolitano C, Gasparini M. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome : A prospective evaluation of 52 families. Circulation. 2000;102:2509–2515[Abstract/Free Full Text]
  377. Dumaine R, Towbin JA, Brugada P. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803–809[Abstract/Free Full Text]
  378. Brugada R, Brugada J, Antzelevitch C. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000;101:510–515[Abstract/Free Full Text]
  379. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J. 1978;40:28–37
  380. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–1519[Abstract/Free Full Text]
  381. de Paola AA, Horowitz LN, Marques FB. Control of multiform ventricular tachycardia by propranolol in a child with no identifiable cardiac disease and sudden death. Am Heart J. 1990;119:1429–1432[CrossRef][Web of Science][Medline]
  382. Noh CI, Gillette PC, Case CL, Zeigler VL. Clinical and electrophysiological characteristics of ventricular tachycardia in children with normal hearts. Am Heart J. 1990;120:1326–1333[CrossRef][Web of Science][Medline]
  383. Swan H, Piippo K, Viitasalo M. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999;34:2035–2042[Abstract/Free Full Text]
  384. Rosen MR, Danilo P Jr. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on Ouabain-induced delayed afterdepolarizations in canine Purkinje fibers. Circ Res. 1980;46:117–124[Free Full Text]
  385. Marks AR. Cardiac intracellular calcium release channels: role in heart failure. Circ Res. 2000;87:8–11[Free Full Text]
  386. Priori SG, Napolitano C, Tiso N. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200[Abstract/Free Full Text]
  387. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38:61–67[Medline]
  388. Otto CM, Burwash IG, Legget ME. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262–2270[Abstract/Free Full Text]
  389. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9:57–64[Abstract]
  390. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, haemodynamically significant aortic stenosis. J Am Coll Cardiol. 1990;15:1012–1017[Abstract]
  391. Lund O, Nielsen TT, Emmertsen K. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg. 1996;44:289–295[Web of Science][Medline]
  392. Olshausen KV, Witt T, Pop T, Treese N, Bethge KP, Meyer J. Sudden cardiac death while wearing a Holter monitor. Am J Cardiol. 1991;67:381–386[CrossRef][Web of Science][Medline]
  393. Dhingra RC, Leon F, Pietras RJ. Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification. Ann Intern Med. 1977;87:275–280[Abstract/Free Full Text]
  394. Darbar D, Cherry CJ, Kerins DM. QT dispersion is reduced after valve replacement in patients with aortic stenosis. Heart. 1999;82:15–18[Abstract/Free Full Text]
  395. Sorgato A, Faggiano P, Simoncelli U, Rusconi C. Prevalence of late potentials in adult aortic stenosis. Int J Cardiol. 1996;53:55–59[CrossRef][Web of Science][Medline]
  396. Ducceschi V, Sarubbi B, D'Andrea A. Increased QT dispersion and other repolarization abnormalities as a possible cause of electrical instability in isolated aortic stenosis. Int J Cardiol. 1998;64:57–62[CrossRef][Web of Science][Medline]
  397. Martinez-Rubio A, Schwammenthal Y, Schwammenthal E. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation. 1997;96:500–508[Abstract/Free Full Text]
  398. Braunwald E. Commentary. Cardiol Rev. 1993;1:349
  399. Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg. 1988;95:390–401[Abstract]
  400. Gohlke-Barwolf C, Peters K, Petersen J. Influence of aortic valve replacement on sudden death in patients with pure aortic stenosis. Eur Heart J. 1988;9:139–141[CrossRef][Web of Science][Medline]
  401. Foppl M, Hoffmann A, Amann FW. Sudden cardiac death after aortic valve surgery: incidence and concomitant factors. Clin Cardiol. 1989;12:202–207[Web of Science][Medline]
  402. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation. 1985;72:753–767[Abstract/Free Full Text]
  403. Keefe DL, Griffin JC, Harrison DC, Stinson EB. Atrioventricular conduction abnormalities in patients undergoing isolated aortic or mitral valve replacement. Pacing Clin Electrophysiol. 1985;8:393–398[CrossRef][Medline]
  404. Boughaleb D, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. Permanent cardiac stimulation after aortic valve replacement: incidence, predictive factors and long-term prognosis. Arch Mal Coeur Vaiss. 1994;87:925–930[Web of Science][Medline]
  405. Cheitlin MD, Alpert JS, Armstrong WF. ACC/AHA Guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in colloboration with the American Society of Echocardiography. Circulation. 1997;95:1686–1744[Free Full Text]
  406. Freed LA, Levy D, Levine RA. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1–7[Abstract/Free Full Text]
  407. Curtius JM, Bents R, Bungard U. Clinical course of 470 patients with mitral valve prolapse. Z Kardiol. 1986;75:1–7[Web of Science][Medline]
  408. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol. 1995;75:1028–1032[CrossRef][Web of Science][Medline]
  409. Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation. Pacing Clin Electrophysiol. 1993;16:387–393[CrossRef][Medline]
  410. Corrado D, Basso C, Nava A, Rossi L, Thiene G. Sudden death in young people with apparently isolated mitral valve prolapse. G Ital Cardiol. 1997;27:1097–1105[Medline]
  411. Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med. 1985;313:1305–1309[Abstract]
  412. Boudoulas H, Schaal SF, Stang JM, Fontana ME, Kolibash AJ, Wooley CF. Mitral valve prolapse: cardiac arrest with long-term survival. Int J Cardiol. 1990;26:37–44[CrossRef][Web of Science][Medline]
  413. Babuty D, Cosnay P, Breuillac JC. Ventricular arrhythmia factors in mitral valve prolapse. Pacing Clin Electrophysiol. 1994;17:1090–1099[CrossRef][Medline]
  414. Campbell RW, Godman MG, Fiddler GI, Marquis RM, Julian DG. Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group. Br Heart J. 1976;38:1053–1057[Abstract/Free Full Text]
  415. Tieleman RG, Crijns HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J. 1995;73:37–40[Abstract/Free Full Text]
  416. Kulan K, Komsuoglu B, Tuncer C, Kulan C. Significance of QT dispersion on ventricular arrhythmias in mitral valve prolapse. Int J Cardiol. 1996;54:251–257[CrossRef][Web of Science][Medline]
  417. Savage DD, Garrison RJ, Devereux RB. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J. 1983;106:571–576[CrossRef][Web of Science][Medline]
  418. Angelini P. Normal and anomalous coronary arteries: definitions and classification. Am Heart J. 1989;117:418–434[CrossRef][Web of Science][Medline]
  419. Kimbiris D, Iskandrian AS, Segal BL, Bemis CE. Anomalous aortic origin of coronary arteries. Circulation. 1978;58:606–615[Free Full Text]
  420. Liberthson RR, Dinsmore RE, Fallon JT. Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management. Circulation. 1979;59:748–754[Abstract/Free Full Text]
  421. Click RL, Holmes DR, Vlietstra RE, Kosinski AS, Kronmal RA. Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival—a report from the Coronary Artery Surgery Study. J Am Coll Cardiol. 1989;13:531–537[Abstract]
  422. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva, A not-so-minor congenital anomaly. Circulation. 1974;50:780–787[Abstract/Free Full Text]
  423. Viskin S, Belhassen B, Paredes A, Yakirevich V, Miller H, Laniado S. Anomalous origin of the left coronary artery from the pulmonary artery: report of an adult with ventricular fibrillation as the presenting symptom. Am Heart J. 1992;124:221–222[CrossRef][Web of Science][Medline]
  424. Menahem S, Venables AW. Anomalous left coronary artery from the pulmonary artery: a 15 year sample. Br Heart J. 1987;58:378–384[Abstract/Free Full Text]
  425. Karr SS, Parness IA, Spevak PJ, van der Velde ME, Colan SD, Sanders SP. Diagnosis of anomalous left coronary artery by Doppler color flow mapping: distinction from other causes of dilated cardiomyopathy. J Am Coll Cardiol. 1992;19:1271–1275[Abstract]
  426. Fernandes F, Alam M, Smith S, Khaja F. The role of transesophageal echocardiography in identifying anomalous coronary arteries. Circulation. 1993;88:2532–2540[Abstract/Free Full Text]
  427. Kochman W, Dabrowski M, Ruzyllo W. Myocardial bridging as an isolated angiographic change in the anterior descending branch of the left coronary artery. Kardiol Pol. 1990;33:27–33[Medline]
  428. Ishii T, Hosoda Y, Osaka T. The significance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery. J Pathol. 1986;148:279–291[CrossRef][Web of Science][Medline]
  429. Ge J, Jeremias A, Rupp A. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J. 1999;20:1707–1716[Abstract/Free Full Text]
  430. Bestetti RB, Costa RS, Zucolotto S, Oliveira JS. Fatal outcome associated with autopsy proven myocardial bridging of the left anterior descending coronary artery. Eur Heart J. 1989;10:573–576[Abstract/Free Full Text]
  431. Desseigne P, Tabib A, Loire R. Myocardial bridging on the left anterior descending coronary artery and sudden death. Apropos of 19 cases with autopsy. Arch Mal Coeur Vaiss. 1991;84:511–516[Web of Science][Medline]
  432. Cutler D, Wallace JM. Myocardial bridging in a young patient with sudden death. Clin Cardiol. 1997;20:581–583[Web of Science][Medline]
  433. Tio RA, Van Gelder IC, Boonstra PW, Crijns HJ. Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart. 1997;77:280–282[Abstract/Free Full Text]
  434. Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy—a risk factor for sudden death. N Engl J Med. 1998;339:1201–1209[Abstract/Free Full Text]
  435. Schwarz ER, Klues HG, Vom DJ, Klein I, Krebs W, Hanrath P. Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol. 1996;27:1637–1645[Abstract]
  436. Stables RH, Knight CJ, McNeill JG, Sigwart U. Coronary stenting in the management of myocardial ischaemia caused by muscle bridging. Br Heart J. 1995;74:90–92[Abstract/Free Full Text]
  437. Prasad VS, Shivaprakash K, Arumugan SB, Cherian KM. Modified supra-arterial myotomy for intermittent coronary obstruction by myocardial bridges. Scand J Thorac Cardiovasc Surg. 1995;29:91–93[Web of Science][Medline]
  438. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den DA, Wellens HJ. Aborted sudden death in the Wolff–Parkinson–White syndrome. Am J Cardiol. 1995;76:492–494[CrossRef][Web of Science][Medline]
  439. Munger TM, Packer DL, Hammill SC. A population study of the natural history of Wolff–Parkinson–White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation. 1993;87:866–873[Abstract/Free Full Text]
  440. Goudevenos JA, Katsouras CS, Graekas G, Argiri O, Giogiakas V, Sideris DA. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart. 2000;83:29–34[Abstract/Free Full Text]
  441. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff–Parkinson–White syndrome. N Engl J Med. 1979;301:1080–1085[Abstract]
  442. Beckman KJ, Gallastegui JL, Bauman JL, Hariman RJ. The predictive value of electrophysiologic studies in untreated patients with Wolff–Parkinson–White syndrome. J Am Coll Cardiol. 1990;15:640–647[Abstract]
  443. Attoyan C, Haissaguerre M, Dartigues JF, Le Metayer P, Warin JF, Clementy J. Ventricular fibrillation in Wolff–Parkinson–White syndrome. Predictive factors. Arch Mal Coeur Vaiss. 1994;87:889–897[Web of Science][Medline]
  444. Montoya PT, Brugada P, Smeets J. Ventricular fibrillation in the Wolff–Parkinson–White syndrome. Eur Heart J. 1991;12:144–150[Abstract/Free Full Text]
  445. Wellens HJ, Bar FW, Gorgels AP, Vanagt EJ. Use of ajmaline in patients with the Wolff–Parkinson–White syndrome to disclose short refractory period of the accessory pathway. Am J Cardiol. 1980;45:130–133[CrossRef][Web of Science][Medline]
  446. Auricchio A, Klein H, Trappe HJ, Wenzlaff P. Lack of prognostic value of syncope in patients with Wolff–Parkinson–White syndrome. J Am Coll Cardiol. 1991;17:152–158[Abstract]
  447. Brembilla-Perrot B, Ghawi R. Electrophysiological characteristics of asymptomatic Wolff–Parkinson–White syndrome. Eur Heart J. 1993;14:511–515[Abstract/Free Full Text]
  448. Leitch JW, Klein GJ, Yee R, Murdock C. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff–Parkinson–White pattern. Circulation. 1990;82:1718–1723[Abstract/Free Full Text]
  449. Zipes DP, DiMarco JP, Gillette PC. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 1995;26:555–573[CrossRef][Web of Science][Medline]
  450. Nikolic G, Bishop RL, Singh JB. Sudden death recorded during Holter monitoring. Circulation. 1982;66:218–225[Abstract/Free Full Text]
  451. Schmidinger H, Weber H. Sudden death during ambulatory Holter monitoring. Int J Cardiol. 1987;16:169–176[CrossRef][Web of Science][Medline]
  452. Feruglio G, Rickards A, Steinbach K. Cardiac Pacing in the world: A survey of the state of the art in 1986. Pacing Clin Electrophysiol. 1987;10:768–777
  453. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J. 1980;280:139–141[Abstract/Free Full Text]
  454. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988;116:16–22[CrossRef][Web of Science][Medline]
  455. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation. 1999;99:406–410[Abstract/Free Full Text]
  456. Andersen HR, Nielsen JC, Thomsen PE. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210–1216[CrossRef][Web of Science][Medline]
  457. Fisch GR, Zipes DP, Fisch C. Bundle branch block and sudden death. Prog Cardiovasc Dis. 1980;23:187–224[CrossRef][Web of Science][Medline]
  458. McAnulty JH, Rahimtoola SH, Murphy E. Natural history of ‘high-risk’ bundle-branch block: final report of a prospective study. N Engl J Med. 1982;307:137–143[Abstract]
  459. Dhingra RC, Denes P, Wu D, Chuquimia R, Rosen KM. The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block. Circulation. 1974;49:638–646[Abstract/Free Full Text]
  460. Br Heart J. 1991;66:185–191[Free Full Text]
  461. Shaw DB, Kekwick CA, Veale D, Gowers J, Whistance T. Survival in second degree atrioventricular block. Br Heart J. 1985;53:587–593[Abstract/Free Full Text]
  462. Johansson BW. Complete heart block. A clinical, haemodynamic and pharmacological study in patients with and without an artificial pacemaker. Acta Med Scand Suppl. 1966;451:1–127[Medline]
  463. Strasberg B, Amat YL, Dhingra RC. Natural history of chronic second-degree atrioventricular nodal block. Circulation. 1981;63:1043–1049[Abstract/Free Full Text]
  464. Edhag O, Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. Acta Med Scand. 1976;200:457–463[Web of Science][Medline]
  465. Hindman MC, Wagner GS, JaRo M. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. Circulation. 1978;58:689–699[Abstract/Free Full Text]
  466. Denes P, Dhingra RC, Wu D, Wyndham CR, Leon F, Rosen KM. Sudden death in patients with chronic bifascicular block. Arch Intern Med. 1977;137:1005–1010[Abstract/Free Full Text]
  467. Dhingra RC, Amat YL, Wyndham C, Sridhar SS, Wu D, Rosen KM. Significance of left axis deviation in patients with chronic left bundle branch block. Am J Cardiol. 1978;42:551–556[CrossRef][Web of Science][Medline]
  468. Ezri M, Lerman BB, Marchlinski FE, Buxton AE, Josephson ME. Electrophysiologic evaluation of syncope in patients with bifascicular block. Am Heart J. 1983;106:693–697[CrossRef][Web of Science][Medline]
  469. Morady F, Higgins J, Peters RW. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol. 1984;54:587–591[CrossRef][Web of Science][Medline]
  470. Twidale N, Heddle WF, Ayres BF, Tonkin AM. Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. Aust N Z J Med. 1988;18:841–847[Web of Science][Medline]
  471. Dhingra RC, Wyndham C, Bauernfeind R. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation. 1979;60:1455–1464[Abstract/Free Full Text]
  472. Click RL, Gersh BJ, Sugrue DD. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 1987;59:817–823[CrossRef][Web of Science][Medline]
  473. Peters RW, Scheinman MM, Modin C, O'Young J, Somelofski CA, Mies C. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med. 1979;66:978–985[CrossRef][Web of Science][Medline]
  474. Scheinman MM, Peters RW, Suave MJ. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982;50:1316–1322[CrossRef][Web of Science][Medline]
  475. Scheinman MM, Weiss AN, Shafton E, Benowitz N, Rowland M. Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay. Circulation. 1974;49:522–529[Abstract/Free Full Text]
  476. Tonkin AM, Heddle WF, Tornos P. Intermittent atrioventricular block: procainamide administration as a provocative test. Aust N Z J Med. 1978;8:594–602[Web of Science][Medline]
  477. Clemmensen P, Bates ER, Califf RM. Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. Am J Cardiol. 1991;67:225–230[CrossRef][Web of Science][Medline]
  478. Behar S, Zissman E, Zion M. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. Am J Cardiol. 1993;72:831–834[CrossRef][Web of Science][Medline]
  479. Berger PB, Ruocco NA, Ryan TJ, Frederick MM, Jacobs AK, Faxon DP. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol. 1992;20:533–540[Abstract]
  480. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol. 1972;29:344–350[CrossRef][Web of Science][Medline]
  481. Ginks WR, Sutton R, Oh W, Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J. 1977;39:186–189[Abstract/Free Full Text]
  482. Lamas GA, Muller JE, Turi ZG. A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol. 1986;57:1213–1219[CrossRef][Web of Science][Medline]
  483. Sholler GF, Walsh EP. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J. 1989;118:1193–1198[CrossRef][Web of Science][Medline]
  484. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation. 1995;92:442–449[Abstract/Free Full Text]
  485. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin. 1972;4:85–101[Medline]
  486. Solti F, Szatmary L, Vecsey T, Renyi-Vamos F, Bodor E. Congenital complete heart block associated with QT prolongation. Eur Heart J. 1992;13:1080–1083[Abstract/Free Full Text]
  487. Silka MJ, Manwill JR, Kron J, McAnulty JH. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol. 1990;65:488–493[CrossRef][Web of Science][Medline]
  488. Patel VS, Lim M, Massin EK. Sudden cardiac death in cardiac transplant recipients. Circulation. 1996;94:II273–II277[Medline]
  489. Leonelli FM, Dunn JK, Young JB, Pacifico A. Natural history, determinants, and clinical relevance of conduction abnormalities following orthotopic heart transplantation. Am J Cardiol. 1996;77:47–51[CrossRef][Web of Science][Medline]
  490. Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol. 1997;20:343–348[CrossRef][Medline]
  491. Kappos KG, Kranidis AJ, Anthopoulos LP. Torsades de pointes following radiofrequency catheter His ablation. Int J Cardiol. 1996;57:177–179[CrossRef][Web of Science][Medline]
  492. Satoh T, Zipes DP. Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation. 1996;94:217–227[Abstract/Free Full Text]
  493. Maron BJ, Isner JM, McKenna WJ. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol. 1994;24:880–885[Web of Science][Medline]
  494. Maron BJ. Sudden death in young athletes. Lessons from the Hank Gathers affair. N Engl J Med. 1993;329:55–57[Free Full Text]
  495. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med. 1998;129:379–386[Abstract/Free Full Text]
  496. Maron BJ, Mitten MJ, Quandt EF, Zipes DP. Competitive athletes with cardiovascular disease—the case of Nicholas Knapp. N Engl J Med. 1998;339:1632–1635[Free Full Text]
  497. Thompson PD, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247:2535–2538[Abstract/Free Full Text]
  498. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874–877[Abstract]
  499. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol. 1996;28:428–431[Abstract]
  500. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol. 1998;32:1881–1884[Abstract/Free Full Text]
  501. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641–647
  502. Burke AP, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J. 1991;121:568–575[CrossRef][Web of Science][Medline]
  503. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334:1039–1044[Free Full Text]
  504. Virmani R, Robinowitz M, McAllister HA Jr. Nontraumatic death in joggers. A series of 30 patients at autopsy. Am J Med. 1982;72:874–882[CrossRef][Web of Science][Medline]
  505. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986;7:204–214[Abstract]
  506. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91:1596–1601[Free Full Text]
  507. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295–301[Abstract]
  508. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130:23–31[Abstract/Free Full Text]
  509. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276:211–215[Abstract/Free Full Text]
  510. Roberts WC, Kragel AH. Anomalous origin of either the right or left main coronary artery from the aorta without coursing of the anomalistically arising artery between aorta and pulmonary trunk. Am J Cardiol. 1988;62:1263–1267[CrossRef][Web of Science][Medline]
  511. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493–1501[Abstract/Free Full Text]
  512. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience [editorial]. Am J Cardiol. 1995;75:827–829[CrossRef][Web of Science][Medline]
  513. Maron BJ, Thompson PD, Puffer JC. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation. 1996;94:850–856[Free Full Text]
  514. Glover DW, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes. JAMA. 1998;279:1817–1819[Abstract/Free Full Text]
  515. Pfister GC, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for collegiate student-athletes. JAMA. 2000;283:1597–1599[Abstract/Free Full Text]
  516. Maron BJ, Moller JH, Seidman CE. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association. Circulation. 1998;98:1460–1471[Medline]
  517. Priori SG, Broggrefe M, Camm AJ. Role of the implantable cardioverter defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE international registry. Pacing Clin Electrophysiol. 2001;18:799[CrossRef]
  518. Priori SG, Crotti L. Idiopathic ventricular fibrillation. Cardiac Electrophysiol Rev. 1999;3:198–201[CrossRef]
  519. Peeters HA, Sippensgroenewegen A, Wever EF. Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation. J Am Coll Cardiol. 1998;31:1406–1413[Abstract/Free Full Text]
  520. Schaefers M, Wichter T, Lerch H. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med. 1999;40:1–5[Abstract/Free Full Text]
  521. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol. 1993;4:356–368[Web of Science][Medline]
  522. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA. 1986;256:2696–2699[Abstract/Free Full Text]
  523. Lecomte D, Fornes P, Fouret P, Nicolas G. Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis. J Forensic Sci. 1993;38:617–621[Web of Science][Medline]
  524. Fontaine G, Fornes P, Fontaliran F, Zipes DP, Wellens HJJ. Myocarditis as a cause of sudden death response. Circulation. 2001;103:e12[Free Full Text]
  525. Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson C. Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet. 1992;340:427–428[Web of Science][Medline]
  526. Akhtar N, Ni J, Stromberg D, Rosenthal GL, Bowles NE, Towbin JA. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation. 1999;99:2011–2018[Abstract/Free Full Text]
  527. Basso C, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation. 2001;103:269–275[Abstract/Free Full Text]
  528. Maron BJ, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333:337–342[Abstract/Free Full Text]
  529. Maron BJ, Link MS, Wang PJ, Estes NA III. Clinical profile of commotio cordis: an under appreciated cause of sudden death in the young during sports and other activities. J Cardiovasc Electrophysiol. 1999;10:114–120[Web of Science][Medline]
  530. Maron BJ, Gohman T, Estes N, Link MS. The clinical spectrum of commotio cordis: The first 100 cases from the U.S. Registry. Circulation. 1998;102:
  531. Link MS, Wang PJ, Pandian NG. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med. 1998;338:1805–1811[Abstract/Free Full Text]
  532. Link MS, Wang PJ, VanderBrink BA. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation. 1999;100:413–418[Abstract/Free Full Text]
  533. Maron BJ, Strasburger JF, Kugler JD, Bell BM, Brodkey FD, Poliac LC. Survival following blunt chest impact-induced cardiac arrest during sports activities in young athletes. Am J Cardiol. 1997;79:840–841[CrossRef][Web of Science][Medline]
  534. Haverkamp W, Breithardt G, Camm AJ. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J. 2000;21:1216–1231[Free Full Text]
  535. Tamargo J. Drug-induced torsade de pointes: from molecular biology to bedside. Jpn J Pharmacol. 2000;83:1–19[CrossRef][Medline]
  536. Lazzara R. Amiodarone and torsade de pointes. Ann Intern Med. 1989;111:549–551[CrossRef][Web of Science][Medline]
  537. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation. 1992;86:1376–1382[Abstract/Free Full Text]
  538. Mattioni TA, Zheutlin TA, Sarmiento JJ, Parker M, Lesch M, Kehoe RF. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Ann Intern Med. 1989;111:574–580[Abstract/Free Full Text]
  539. Crumb WJ, Wible B, Arnold DJ, Payne JP, Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol. 1995;47:181–190[Abstract]
  540. Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 1996;385:77–80[CrossRef][Web of Science][Medline]
  541. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther. 1992;52:231–238[Web of Science][Medline]
  542. Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996;59:383–388[CrossRef][Web of Science][Medline]
  543. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moye L. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol. 1994;73:346–352[CrossRef][Web of Science][Medline]
  544. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol. 1996;36:233–252[CrossRef][Web of Science][Medline]
  545. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol. 1996;28:1836–1848[Abstract]
  546. Stramba-Badiale M, Guffanti S, Porta N, Frediani M, Beria G, Colnaghi C. QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant. Am Heart J. 1993;126:740–742[CrossRef][Web of Science][Medline]
  547. Daleau P, Lessard E, Groleau MF, Turgeon J. Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation. 1995;91:3010–3016[Abstract/Free Full Text]
  548. Wiener I, Rubin DA, Martinez E, Postman J, Herman MV. QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration. Mt Sinai J Med. 1981;48:53–55[Medline]
  549. Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987;59:376–377[CrossRef][Web of Science][Medline]
  550. Sesti F, Abbott GW, Wei J. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A. 2000;97:10613–10618[Abstract/Free Full Text]
  551. Ball P. Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. J Antimicrob Chemother. 2000;45:557–559[Free Full Text]
  552. Adamantidis MM, Dumotier BM, Caron JF, Bordet R. Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers. Fundam Clin Pharmacol. 1998;12:70–76[Web of Science][Medline]
  553. Gonzalez FJ, Idle JR. Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet. 1994;26:59–70[Web of Science][Medline]
  554. Sheets JJ, Mason JI, Wise CA, Estabrook RW. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents. Biochem Pharmacol. 1986;35:487–491[CrossRef][Web of Science][Medline]
  555. Dumaine R, Roy ML, Brown AM. Blockade of HERG and Kv1.5 by ketoconazole. J Pharmacol Exp Ther. 1998;286:727–735[Abstract/Free Full Text]
  556. White NJ, Looareesuwan S, Warrell DA. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol. 1983;5:173–175[Web of Science][Medline]
  557. Karbwang J, Davis TM, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol. 1993;35:265–271[Web of Science][Medline]
  558. Nosten F, ter Kuile FO, Luxemburger C. Cardiac effects of antimalarial treatment with halofantrine. Lancet. 1993;341:1054–1056[CrossRef][Web of Science][Medline]
  559. Sowunmi A, Falade C, Adedeji A. Patterns of change in the electrocardiogram after halofantrine treatment of acute uncomplicated falciparum in children. Clin Drug Invest. 2000;20:229–236[CrossRef]
  560. Bustos MD, Gay F, Diquet B, Thomare P, Warot D. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop Med Parasitol. 1994;45:83–86[Web of Science][Medline]
  561. Sartori M, Pratt CM, Young JB. Torsade de Pointe. Malignant cardiac arrhythmia induced by amantadine poisoning. Am J Med. 1984;77:388–391[CrossRef][Web of Science][Medline]
  562. Mehtonen OP, Aranko K, Malkonen L, Vapaatalo H. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand. 1991;84:58–64[Web of Science][Medline]
  563. Jackson T, Ditmanson L, Phibbs B. Torsade de pointes and low-dose oral haloperidol. Arch Intern Med. 1997;157:2013–2015[Abstract/Free Full Text]
  564. Lawrence KR, Nasraway SA. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy. 1997;17:531–537[Web of Science][Medline]
  565. Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci. 1997;42:335–339[Web of Science][Medline]
  566. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335:290–291[Free Full Text]
  567. Henney J. Withdrawal of troglitazone and cisapride. JAMA. 2000;283:2228[Free Full Text]
  568. Herlitz J, Bahr J, Fischer M, Kuisma M, Lexow K, Thorgeirsson G. Resuscitation in Europe: a tale of five European regions. Resuscitation. 1999;41:121–131[CrossRef][Web of Science][Medline]
  569. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;343:1206–1209[Abstract/Free Full Text]
  570. Holmberg M, Holmberg S, Herlitz J, Gardelov B. Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry. Resuscitation. 1998;36:29–36[CrossRef][Web of Science][Medline]
  571. Tunstall-Pedoe H, Bailey L, Chamberlain DA, Marsden AK, Ward ME, Zideman DA. Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results. BMJ. 1992;304:1347–1351[Abstract/Free Full Text]
  572. Mullie A, Lewi P, Van Hoeyweghen R. Pre-CPR conditions and the final outcome of CPR. The Cerebral Resuscitation Study Group. Resuscitation. 1989;17:S11–S21[Medline]
  573. Becker LB, Ostrander MP, Barrett J, Kondos GT. Outcome of CPR in a large metropolitan area—where are the survivors? Ann Emerg Med. 1991;20:355–361[CrossRef][Web of Science][Medline]
  574. Circulation. 2000;102:
  575. JAMA. 1974;227:833–868[Web of Science]
  576. Bossaert L. European Resuscitation Council guidelines for Resuscitation. Amsterdam: Elsevier; 1998.
  577. Cummins RO, Chamberlain DA. Advisory statements of the International Liaison Committee on Resuscitation. Circulation. 1997;95:2172–2173[Free Full Text]
  578. Resuscitation. 2000;46:1–448[CrossRef][Medline]
  579. Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A study of chest compression rates during cardiopulmonary resuscitation in humans. The importance of rate-directed chest compressions. Arch Intern Med. 1992;152:145–149[Abstract/Free Full Text]
  580. Schneider T, Martens PR, Paschen H. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation. 2000;102:1780–1787[Abstract/Free Full Text]
  581. Cummins RO, Chamberlain D, Hazinski MF. Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. A statement for healthcare professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Australian Resuscitation Council, and the Resuscitation Councils of Southern Africa. Resuscitation. 1997;34:151–183[CrossRef][Web of Science][Medline]
  582. White RD, Asplin BR, Bugliosi TF, Hankins DG. High discharge survival rate after out-of-hospital ventricular fibrillation with rapid defibrillation by police and paramedics. Ann Emerg Med. 1996;28:480–485[CrossRef][Web of Science][Medline]
  583. Mosesso VN Jr, Davis EA, Auble TE, Paris PM, Yealy DM. Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest. Ann Emerg Med. 1998;32:200–207[CrossRef][Web of Science][Medline]
  584. O'Rourke MF, Donaldson E, Geddes JS. An airline cardiac arrest program. Circulation. 1997;96:2849–2853[Abstract/Free Full Text]
  585. Page RL, Hamdan MH, McKenas DK. Defibrillation aboard a commercial aircraft. Circulation. 1998;97:1429–1430[Free Full Text]
  586. Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC Jr. Public access defibrillation. A statement for healthcare professionals from the American Heart Association Task Force on Automatic External Defibrillation. Circulation. 1995;92:2763[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
M. Eijgelsheim, C. Newton-Cheh, A. L.H.J. Aarnoudse, C. van Noord, J. C.M. Witteman, A. Hofman, A. G. Uitterlinden, and B. H.C. Stricker
Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study
Hum. Mol. Genet., November 1, 2009; 18(21): 4213 - 4218.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Knecht, F. Sacher, M. Wright, M. Hocini, A. Nogami, T. Arentz, B. Petit, R. Franck, C. De Chillou, D. Lamaison, et al.
Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study.
J. Am. Coll. Cardiol., August 4, 2009; 54(6): 522 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Genovesi, M. G. Valsecchi, E. Rossi, D. Pogliani, I. Acquistapace, V. De Cristofaro, A. Stella, and A. Vincenti
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2529 - 2536.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
M. Haghjoo, S. Mohammadzadeh, M. Taherpour, B. Faghfurian, A. F. Fazelifar, A. Alizadeh, M. A. Rad, and M. A. Sadr-Ameli
ST-segment depression as a risk factor in hypertrophic cardiomyopathy
Europace, May 1, 2009; 11(5): 643 - 649.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M. S. Maron, S. Bongioanni, F. Coccolo, N.A. M. Estes, C. S. Barilla, et al.
Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Circulation, April 7, 2009; 119(13): 1703 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
A. Bauer, J. Mehilli, P. Barthel, A. Muller, A. Kastrati, K. Ulm, A. Schomig, M. Malik, and G. Schmidt
Impact of Myocardial Salvage Assessed by 99mTc-Sestamibi Scintigraphy on Cardiac Autonomic Function in Patients Undergoing Mechanical Reperfusion Therapy for Acute Myocardial Infarction
J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 449 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Ther Adv Cardiovasc DisHome page
R. Shephard and C. Semsarian
Advances in the prevention of sudden cardiac death in the young
Therapeutic Advances in Cardiovascular Disease, April 1, 2009; 3(2): 145 - 155.
[Abstract] [PDF]

Home page
 EuropaceHome page
U. Ravens and E. Cerbai
Role of potassium currents in cardiac arrhythmias
Europace, October 1, 2008; 10(10): 1133 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Byrne, O. Constant, Y. Smyth, G. Callagy, P. Nash, K. Daly, and J. Crowley
Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland
Eur. Heart J., June 1, 2008; 29(11): 1418 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
D. Chase, P. J. Roderick, H. Burnley, P. J. Gallagher, P. R. Roberts, and J. M. Morgan
Is there unmet need for implantable cardioverter defibrillators? Findings from a post-mortem series of sudden cardiac death
Europace, June 1, 2008; 10(6): 741 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]

Home page
 CirculationHome page
Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]

Home page
 CJASNHome page
E. Ritz and C. Wanner
The Challenge of Sudden Death in Dialysis Patients
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 920 - 929.
[Full Text] [PDF]

Home page
 EuropaceHome page
D. P. Gibson, K. K. Kuntz, J. L. Levenson, and K. A. Ellenbogen
Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator
Europace, May 1, 2008; 10(5): 540 - 544.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Nazarian and J. A.C. Lima
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1375 - 1376.
[Full Text] [PDF]

Home page
 EuropaceHome page
T. Rauwolf, M. Guenther, N. Hass, A. Schnabel, M. Bock, M.U. Braun, and R.H. Strasser
Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions
Europace, November 1, 2007; 9(11): 1041 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Paul, J. Gerss, E. Schulze-Bahr, T. Wichter, C. Vahlhaus, A. A.M. Wilde, G. Breithardt, and L. Eckardt
Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data
Eur. Heart J., September 1, 2007; 28(17): 2126 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
B. Darpo
Detection and reporting of drug-induced proarrhythmias: room for improvement
Europace, September 1, 2007; 9(suppl_4): iv23 - iv36.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]

Home page
 CirculationHome page
A.-J. L.H.J. Aarnoudse, C. Newton-Cheh, P. I.W. de Bakker, S. M.J.M. Straus, J. A. Kors, A. Hofman, A. G. Uitterlinden, J. C.M. Witteman, and B. H.C. Stricker
Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study
Circulation, July 3, 2007; 116(1): 10 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
G. Thomas, I. S. Gurung, M. J. Killeen, P. Hakim, C. A. Goddard, M. P. Mahaut-Smith, W. H. Colledge, A. A. Grace, and C. L.-H. Huang
Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3
J. Physiol., January 1, 2007; 578(1): 85 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. Boriani, M. Biffi, C. Valzania, G. Bronzetti, and C. Martignani
Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children
Eur. Heart J., October 2, 2006; 27(20): 2382 - 2384.
[Full Text] [PDF]

Home page
 QJMHome page
M.F. Oliver
Sudden cardiac death: the lost fatty acid hypothesis
QJM, October 1, 2006; 99(10): 701 - 709.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140.
[Full Text] [PDF]

Home page
 EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]

Home page
 EuropaceHome page
M. D. Smit, P. F.H.M. Van Dessel, M. Rienstra, W. Nieuwland, A. C.P. Wiesfeld, E. S. Tan, R. L. Anthonio, D. J. Van Veldhuisen, and I. C. Van Gelder
Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Europace, August 1, 2006; 8(8): 566 - 572.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
A. Pedrote, F. J. Morales, L. Garcia-Riesco, and F. Errazquin
Documented exercise-induced cardiac arrest in a paediatric patient with hypertrophic cardiomyopathy
Europace, June 1, 2006; 8(6): 430 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
J. Watanabe, T. Shinozaki, N. Shiba, K. Fukahori, Y. Koseki, A. Karibe, M. Sakuma, M. Miura, Y. Kagaya, and K. Shirato
Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure
Eur J Heart Fail, May 1, 2006; 8(3): 237 - 242.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. de Torbal, E. Boersma, J. A. Kors, G. van Herpen, J. W. Deckers, D. A.M. van der Kuip, B. H. Stricker, A. Hofman, and J. C.M. Witteman
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study
Eur. Heart J., March 2, 2006; 27(6): 729 - 736.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. Anand, A. N Mooss, and S. M Mohiuddin
Review: Aldosterone Inhibition Reduces the Risk of Sudden Cardiac Death in Patients with Heart Failure
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 15 - 19.
[Abstract] [PDF]

Home page
 HeartHome page
M J Moore, B M Glover, C J McCann, N A Cromie, P Ferguson, D C Catney, F Kee, and A A J Adgey
Demographic and temporal trends in out of hospital sudden cardiac death in Belfast
Heart, March 1, 2006; 92(3): 311 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. M.J.M. Straus, J. A. Kors, M. L. De Bruin, C. S. van der Hooft, A. Hofman, J. Heeringa, J. W. Deckers, J. H. Kingma, M. C.J.M. Sturkenboom, B. H. Ch. Stricker, et al.
Prolonged QTc Interval and Risk of Sudden Cardiac Death in a Population of Older Adults
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 362 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
N. Abdelmawla and A. J. Mitchell
Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms
Adv. Psychiatr. Treat., January 1, 2006; 12(1): 35 - 44.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. J. Wellens, C. Pappone, V. Santinelli, H. J. Wellens, C. Pappone, and V. Santinelli
When to Perform Catheter Ablation in Asymptomatic Patients With a Wolff-Parkinson-White Electrocardiogram
Circulation, October 4, 2005; 112(14): 2201 - 2216.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S. M.J.M. Straus, M. C.J.M. Sturkenboom, G. S. Bleumink, J. P. Dieleman, J. v. d. Lei, P. A. d. Graeff, J. H. Kingma, and B. H.Ch. Stricker
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
Eur. Heart J., October 1, 2005; 26(19): 2007 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
K Lemola, C Brunckhorst, U Helfenstein, E Oechslin, R Jenni, and F Duru
Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre
Heart, September 1, 2005; 91(9): 1167 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. Thorgeirsson, G. Thorgeirsson, H. Sigvaldason, and J. Witteman
Risk factors for out-of-hospital cardiac arrest: the Reykjavik Study
Eur. Heart J., August 1, 2005; 26(15): 1499 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Brugada, R. Brugada, J. Brugada, S. G. Priori, C. Napolitano, P. Brugada, R. Brugada, J. Brugada, S. G. Priori, and C. Napolitano
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?
Circulation, July 12, 2005; 112(2): 279 - 292.
[Full Text] [PDF]

Home page
 CirculationHome page
S. P. Thomas, A. Thiagalingam, E. Wallace, P. Kovoor, and D. L. Ross
Organization of Myocardial Activation During Ventricular Fibrillation After Myocardial Infarction: Evidence for Sustained High-Frequency Sources
Circulation, July 12, 2005; 112(2): 157 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H. Lorenz, C. Junger, K. Seidl, A. Gitt, S. Schneider, R. Schiele, H. Wienbergen, R. Winkler, M. Gottwik, W. Delius, et al.
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?
Eur. Heart J., June 1, 2005; 26(11): 1078 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140.
[Full Text] [PDF]

Home page
 ThoraxHome page
J H Sullivan, A B Schreuder, C A Trenga, S L-J Liu, T V Larson, J Q Koenig, and J D Kaufman
Association between short term exposure to fine particulate matter and heart rate variability in older subjects with and without heart disease
Thorax, June 1, 2005; 60(6): 462 - 466.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. S. Gami, D. E. Howard, E. J. Olson, and V. K. Somers
Day-Night Pattern of Sudden Death in Obstructive Sleep Apnea
N. Engl. J. Med., March 24, 2005; 352(12): 1206 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. R. Flynn, C. Barrett, F. G. Cosio, A. K. Gitt, L. Wallentin, P. Kearney, M. Lonergan, E. Shelley, and M. L. Simoons
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice
Eur. Heart J., February 1, 2005; 26(3): 308 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
E. Vanoli, S. Bacchini, S. Panigada, F. Pentimalli, and P. B Adamson
Experimental models of heart failure
Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F7 - F15.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. Belhassen, A. Glick, and S. Viskin
Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome
Circulation, September 28, 2004; 110(13): 1731 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. G. Priori, C. Napolitano, P. J. Schwartz, M. Grillo, R. Bloise, E. Ronchetti, C. Moncalvo, C. Tulipani, A. Veia, G. Bottelli, et al.
Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With {beta}-Blockers
JAMA, September 15, 2004; 292(11): 1341 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force Members, J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: The Task Force on ACE-inhibitors of the European Society of Cardiology
Eur. Heart J., August 2, 2004; 25(16): 1454 - 1470.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
K. Thygesen and B. F Uretsky
Acute ischaemia as a trigger of sudden cardiac death
Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D88 - D90.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. M. J. M. Straus, G. S. Bleumink, J. P. Dieleman, J. van der Lei, G. W. 't Jong, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. C. Stricker
Antipsychotics and the Risk of Sudden Cardiac Death
Arch Intern Med, June 28, 2004; 164(12): 1293 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. J. Schwartz, S. G. Priori, M. Cerrone, C. Spazzolini, A. Odero, C. Napolitano, R. Bloise, G. M. De Ferrari, C. Klersy, A. J. Moss, et al.
Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome
Circulation, April 20, 2004; 109(15): 1826 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H Weber, K Allikmets, and G Kornfeld
Treating electrical instability in sudden cardiac death survivors - are we looking at the right side of the coin?
Eur. Heart J., April 2, 2004; 25(8): 623 - 625.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S. G. Priori, L. L. Bossaert, D. A. Chamberlain, C. Napolitano, H. R. Arntz, R. W. Koster, K. G. Monsieurs, A. Capucci, and H. J. Wellens
ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe
Eur. Heart J., March 1, 2004; 25(5): 437 - 445.
[Full Text] [PDF]

Home page
 ANGIOLOGYHome page
A. I. Papathanasiou, K. D. Pappas, P. Korantzopoulos, J. P. Leontaridis, T. G. Vougiouklakis, M. Kiriou, V. Dimitroula, L. K. Michalis, and J. A. Goudevenos
An Epidemiologic Study of Acute Coronary Syndromes in Northwestern Greece
Angiology, March 1, 2004; 55(2): 187 - 194.
[Abstract] [PDF]

Home page
 EuropaceHome page
S. G. Priori
From trials to guidelines to clinical practice: the need for improvement
Europace, January 1, 2004; 6(3): 176 - 178.
[Full Text] [PDF]

Home page
 EuropaceHome page
B. Sterk, A.P. van Alem, R. Tukkie, T.A. Simmers, and R.W. Koster
ICD-implantation guidelines versus clinical practice: a prospective study of out-of-hospital cardiac arrest survivors
Europace, January 1, 2004; 6(3): 179 - 183.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
G. Steinbeck, D. Andresen, J. Senges, E. Hoffmann, K. Seidl, J. Brachmann, and for the IRIS investigators as Joint Study of the G
Immediate Risk-Stratification Improves Survival (IRIS): study protocol
Europace, January 1, 2004; 6(5): 392 - 399.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
M. Zecchin, A. Di Lenarda, A. Proclemer, G. Faganello, D. Facchin, E. Petz, and G. Sinagra
The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy
Europace, January 1, 2004; 6(5): 400 - 406.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Thomas, J. Kiehn, H. A Katus, and C. A Karle
Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing
Cardiovasc Res, November 1, 2003; 60(2): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Committee Members, C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1493 - 1531.
[Full Text] [PDF]

Home page
 CirculationHome page
M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, et al.
From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II
Circulation, October 14, 2003; 108(15): 1772 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, B. B. Lerman, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)
Circulation, October 14, 2003; 108(15): 1871 - 1909.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Committee Members, C. Blomstrom-Lundqvist, M. M Scheinman, E. M Aliot, J. S Alpert, H. Calkins, A.J. Camm, W.B. Campbell, D. E Haines, K. H Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society
Eur. Heart J., October 2, 2003; 24(20): 1857 - 1897.
[Full Text] [PDF]

Home page
 HeartHome page
B J Maron
Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy
Heart, September 1, 2003; 89(9): 977 - 978.
[Full Text] [PDF]

Home page
 NEJMHome page
P. T. Ellinor, D. J. Milan, C. A. MacRae, S. G. Priori, P. J. Schwartz, and C. Napolitano
Risk Stratification in the Long-QT Syndrome
N. Engl. J. Med., August 28, 2003; 349(9): 908 - 909.
[Full Text] [PDF]

Home page
 CirculationHome page
H. V. Huikuri, T. H. Makikallio, M. J. P. Raatikainen, J. Perkiomaki, A. Castellanos, and R. J. Myerburg
Prediction of Sudden Cardiac Death: Appraisal of the Studies and Methods Assessing the Risk of Sudden Arrhythmic Death
Circulation, July 8, 2003; 108(1): 110 - 115.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
I. Kardys, J. A Kors, I. M van der Meer, A. Hofman, D. A.M van der Kuip, and J. C.M. Witteman
Spatial QRS-T angle predicts cardiac death in a general population
Eur. Heart J., July 2, 2003; 24(14): 1357 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. C. Saumarez, L. Chojnowska, R. Derksen, M. Pytkowski, M. Sterlinski, C. L.-H. Huang, N. Sadoul, R. N.W. Hauer, W. Ruzyllo, and A. A. Grace
Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation
Circulation, May 27, 2003; 107(20): 2595 - 2600.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. G. Priori, P. J. Schwartz, C. Napolitano, R. Bloise, E. Ronchetti, M. Grillo, A. Vicentini, C. Spazzolini, J. Nastoli, G. Bottelli, et al.
Risk Stratification in the Long-QT Syndrome
N. Engl. J. Med., May 8, 2003; 348(19): 1866 - 1874.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. J.J. Wellens, A. P. Gorgels, and H. de Munter
Cardiac Arrest Outside of a Hospital: How Can We Improve Results of Resuscitation?
Circulation, April 22, 2003; 107(15): 1948 - 1950.
[Full Text] [PDF]

Home page
 StrokeHome page
G. Boriani, M. Gallina, L. Merlini, G. Bonne, D. Toniolo, S. Amati, M. Biffi, C. Martignani, L. Frabetti, M. Bonvicini, et al.
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy: A Long-Term Longitudinal Study
Stroke, April 1, 2003; 34(4): 901 - 908.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. Sullivan, N. Ishikawa, L. Sheppard, D. Siscovick, H. Checkoway, and J. Kaufman
Exposure to Ambient Fine Particulate Matter and Primary Cardiac Arrest among Persons With and Without Clinically Recognized Heart Disease
Am. J. Epidemiol., March 15, 2003; 157(6): 501 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. G Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, J. A Camm, R. Cappato, S. M Cobbe, C. Di Mario, et al.
Update of the guidelines on sudden cardiac death of the European Society of Cardiology
Eur. Heart J., January 1, 2003; 24(1): 13 - 15.
[Full Text] [PDF]

Home page
 EuropaceHome page
E. Moric, E. Herbert, M. Trusz-Gluza, A. Filipecki, U. Mazurek, and T. Wilczok
The implications of genetic mutations in the sodium channel gene (SCN5A)
Europace, January 1, 2003; 5(4): 325 - 334.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Z Abildstrom, C Rask-Madsen, M M Ottesen, P K Andersen, S Rosthoj, C Torp-Pedersen, and L Kober
Impact of age and sex on sudden cardiovascular death following myocardial infarction
Heart, December 1, 2002; 88(6): 573 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Henriques de Gouveia, A.C. van der Wal, C.M. van der Loos, and A.E. Becker
Sudden unexpected death in young adults. Discrepancies between initiation of acute plaque complications and the onset of acute coronary death
Eur. Heart J., September 2, 2002; 23(18): 1433 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Angelini, Z.-J. Zheng, J. B. Croft, W. H. Giles, and G. A. Mensah
Sudden Cardiac Death: Do We Know What We Are Talking About? * Response
Circulation, May 28, 2002; 105 (21): e182 - e182.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (254)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Priori, S.G.
Right arrow Articles by Zipes, D.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priori, S.G.
Right arrow Articles by Zipes, D.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?